Savant Capital’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Buy
19,129
+14,221
+290% +$722K ﹤0.01% 880
2026
Q1
$262K Sell
4,908
-360
-7% -$21.1K ﹤0.01% 1252
2025
Q4
$327K Sell
5,268
-160
-3% -$9.88K ﹤0.01% 1011
2025
Q3
$326K Sell
5,428
-344
-6% -$21K ﹤0.01% 985
2025
Q2
$362K Buy
5,772
+367
+7% +$22.1K ﹤0.01% 880
2025
Q1
$325K Sell
5,405
-502
-8% -$31.2K ﹤0.01% 819
2024
Q4
$345K Buy
+5,907
New +$351K ﹤0.01% 1039

Other funds holding IHI

Savant Capital's IHI Position: Q2 2026 in Review

Savant Capital increased its iShares US Medical Devices ETF (IHI) stake by 290% in Q2 2026, buying an estimated $722K and bringing the position to 19,129 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #880.

Savant Capital first reported a position in IHI in Q4 2024 and has held it in 7 quarters since. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Savant Capital held 19,129 shares of iShares US Medical Devices ETF worth $1.01M as of Q2 2026.
  • Savant Capital bought 14,221 iShares US Medical Devices ETF shares in Q2 2026, an estimated $722K.
  • iShares US Medical Devices ETF made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #880 holding.
  • Savant Capital first reported a position in iShares US Medical Devices ETF in Q4 2024 and has held it in 7 quarters since.
  • 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.